Physicians specializing in the care of patients with lower extremity disorders are acutely aware of the many adverse effects of diabetes mellitus and its secondary complications on all body systems. However, the disease has a devastating socioeconomic impact, as well. An estimated $98 billion in direct and indirect medical costs was spent on diabetes in 1997 in the United States. With a growing older population, cases of diabetes mellitus will certainly increase. The economic impact and clinical effectiveness of patient evaluation, preventive strategies, and treatment options are discussed.
American Orthopaedic Foot and Ankle Society: AOFAS Treatment of the Foot and Ankle: Review Course Manual-2001, Seattle, WA, AOFAS, 2001, p. 65.
5.
ApelqvistJ: Wound healing in diabetes. Outcome and costsClin. Podiatr. Med. Surg.15:21–39, 1998.
6.
ApelqvistJLarssonJAgardhCD: The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcersJ. Diab. Complications4:21–25, 1990.
7.
ApelqvistJRagnarson-TennvallGLarssonJ: Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategiesDiab. Med.12:123–127, 1995.
8.
ApelqvistJRagnarson-TennvallGLarssonJPerssonU: Long-term costs for foot ulcers in diabetic patients in a multidisciplinary settingFoot Ankle Int.16:388–394, 1995.
9.
ApelqvistJRagnarson-TennvallGPerssonULarssonJ: Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputationJ. Intern. Med.235:463–471, 1994.
10.
AssalJP: Cost-effectiveness of diabetes educationPharma-coeconomics8 (suppl 1):68–71, 1995.
11.
AssalJPMuhlhauserIPernetAGfellarRJorgensVBergerM: Patient education as the basis for diabetes care in clinical practice and researchDiabetologia28:602–613, 1985.
12.
BentonGSKersteinMD: Cost effectiveness of early digit amputation in the patient with diabetesSurg. Gynecol. Obstet.161:523, 1985.
13.
BrodskyJW: The diabetic foot In: MannRACoughlinMJ, eds, Surgery of the Foot and Ankle, 7th ed, St. Louis, MO, Mosby-Yearbook, 1999, p. 896.
14.
CallowADMackeyWC: Costs and benefits of prosthetic vascular surgeryInt. Surg.73:237–240, 1988.
15.
CheshireNJWNooneMAWolfeJH: Re-intervention after vascular surgery for critical leg ischaemiaEur. J. Vasc. Surg.6:545–550, 1992.
16.
CheshireNJWWolfeJHNooneMADaviesLDrummondM: The economics of femorocrural reconstruction for critical leg ischemia with and without autologous veinJ. Vasc. Surg.15:167–174, 1992.
17.
CriadoEDe StefanoAAKeagyBAUpchurchGRJrJohnsonGJr: The course of severe foot infection in patients with diabetesSurg. Gynecol. Obstet.175:135–140, 1992.
18.
DavidsonJKAlognaMGoldsmithMBordenJ: Assessment of program effectiveness at Grady Memorial Hospital In: SteinerGLawrencePA, eds, Educating Diabetic Patients, New York, Springer, 1981, pp. 329–348.
19.
EckmanMHGreenfieldSMackeyWC: Foot infections in diabetic patients. Decision and cost-effectiveness analysesJAMA273:712–720, 1995.
20.
EdmondsMEBlundellMPMorrisME: Improved survival of the diabetic foot: the role of a specialized foot clinicQ. J. Med.60:763–771, 1986.
21.
EnerothMApelqvistJTroengTPerssonBM: Operations, total stay and costs of critical leg ischemia. A population-based longitudinal outcome study of 321 patientsActa Orthop. Scand.67:459–465, 1996.
22.
GavinLAStessRMGoldstoneJ: Prevention and treatment of foot problems in diabetes mellitus. A comprehensive programWest. J. Med.158:47–55, 1993.
23.
GibbonsGWMarcaccioEJJrBurgessAM: Improved quality of diabetic foot care, 1984 vs. 1990. Reduced length of stay and costs, insufficient reimbursementArch. Surg.128:576–581, 1993.
24.
GuptaSKVeithFJAscerEFloresSAGliedmanML: Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosisEur. J. Vasc. Surg.2:151–154, 1988.
25.
HarringtonCZagariMJCoreaJKlitenicJ: A cost analysis of diabetic lower-extremity ulcersDiabetes Care23:1333–1338, 2000.
26.
HolsteinPEllitsgaardNSorensonS: Reduced frequency of amputation in diabetic patientsNord. Med.5:142–144, 1996.
27.
JohnsonBFEvansLDruryRDattaDMorris-JonesWBeardJD: Surgery for limb threatening ischaemia: a reappraisal of the costs and benefitsEur. J. Vasc. Endovasc. Surg.9:181–188, 1995.
28.
KantorJMargolisDJ: Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysisDermatol. Surg.27:347–351, 2001.
29.
LarssonJApelqvistJAgardhCDStenstromA: Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? DiabMed.12:770–776, 1995.
30.
LevinMEO'NealLW: The diabetic foot: pathophysiology, evaluation, and treatment In: LevinWMO'NealLW, eds, The Diabetic Foot, 4th ed, St. Louis, MO, Mosby, 1987, p. 17.
31.
LipskyBAPecoraroREWheatLJ: The diabetic foot. Soft-tissue and bone infectionInfect. Dis. Clin. North Am.4:409–432, 1990.
32.
LitzelmanDKSlemendaCWLangefeldCD: Reduction of lower extremity clinical abnormalities in patients with noninsulin-dependent diabetes mellitus. A randomized, controlled trialAnn. Intern. Med.119:36–41, 1993.
33.
LoGerfoFWGibbonsGWPomposelliFBJr: Trends in the care of diabetic foot. Expanded role of arterial reconstructionArch. Surg.127:617–621, 1992.
34.
MackeyWCMcCulloughJLConlonTP: The costs of surgery for limb-threatening ischemiaSurgery99:26–35, 1986.
35.
MaloneJMSnyderMAndersonGBernhardVMHollowayGAJrBuntTJ: Prevention of amputation by diabetic educationAm. J. Surg.158:520–523, 1989.
36.
MillerADVan BuskirkAVerhoek-OftedahlWMillerER: Diabetes-related lower extremity amputations in New Jersey, 1979 to 1981J. Med. Soc. NJ82:723–726, 1985.
37.
MossSEKleinRKleinBE: The prevalence and incidence of lower extremity amputation in a diabetic populationArch. Intern. Med.52:610–616, 1992.
38.
MostRSSinnockP: The epidemiology of lower extremity amputations in diabetic individualsDiabetes Care6:87–91, 1983.
39.
National Diabetes Advisory Board: The Prevention and Treatment of Five Complications of Diabetes: a Guide for Primary Care Practitioners. Atlanta, GA, Centers for Disease Control, 1983.
40.
O'BrienJAShompheLAKavanaghPLRaggioGCaroJJ: Direct medical costs of complications resulting from type 2 diabetes in the US Diabetes Care21:1122–1128, 1998.
41.
OllendorfDAKotsanosJGWishnerWJ: Potential economic benefits of lower-extremity amputation prevention strategies in diabetesDiabetes Care21:1240–1245, 1998.
42.
PatoutCAJrBirkeJAHorswellRWilliamsDCeriseFP: Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American populationDiabetes Care23:1339–1342, 2000.
43.
PecoraroREReiberGEBurgessEM: Pathways to diabetic limb amputation. Basis for preventionDiabetes Care13:513–521, 1990.
44.
Ragnarson-TennvallGApelqvistJ: Cost-effective management of diabetic foot ulcers. A reviewPharmacoeconomics12:42–53, 1997.
45.
RaviolaCANichterLSBakerJDBusuttilRWMachlederHIMooreWS: Cost of treating advanced leg ischemia. Bypass graft vs. primary amputationArch. Surg.123:495–496, 1988.
46.
ReiberGEBoykoEJSmithDG: Lower extremity foot ulcers and amputations in diabetes In: HarrisMICowieCCSternMPBoykoEJReiberGEBennettPH, edis, Diabetes in America, 2nd ed, Washington, DC, U.S. Government Printing Office NIH Publ. No. 95–1468, 1995, pp. 409–428.
47.
ReiberGEPecoraroREKoepsellTD: Risk factors for amputation in patients with diabetes mellitus. A case-control studyAnn. Intern. Med.117:97–105, 1992.
48.
RunyanJWJr: The Memphis chronic disease program. Comparisons in outcome and the nurse's extended roleJAMA231:264–267, 1975.
49.
SillerTACalhounJHMaderJT: Diabetic foot infections: active intervention to preserve functionJ. Muscle Med. Nov:43, 1996.
50.
SmithDMWeinbergerMKatzBP: A controlled trial to increase office visits and reduce hospitalizations of diabetic patientsJ. Gen. Intern. Med.2:232–238, 1987.
51.
The Guide to the Nursing Home Industry: Baltimore, MD, HCFA and Arthur Anderson, 1995.
52.
ThomasS: Cost-effective management of leg ulcersCommunity Outlook March:21–22, 1990.
53.
WetterhallSFOlsonDRDeStefanoF: Trends in diabetes and diabetic complications, 1980–1987Diabetes Care15:960–967, 1992.
